AtaiBeckley Inc. (ATAI)
NASDAQ
Closed
Aug 25, 2026
Day's Range
7.3552 wk Range
3.27Overview - ATAI - AtaiBeckley Inc.
Key Statistics
Valuation
Enterprise Value
2.51B
P/E (Trailing)
‪-2.55‬
P/E (Forward)
‪-15.13‬
PEG Ratio
‪0.05‬
Price / Sales (TTM)
‪614.92‬
Price / Book
‪15.51‬
EV / EBITDA
‪-17.86‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-2,590.43%‬
Return on Assets
‪-39.02%‬
Return on Equity
‪-417.20%‬
Ownership
Shares Outstanding
365.56M
Float
308.41M
Short % of Shares Outstanding
‪6.33%‬
Held by Insiders
‪2.18%‬
Held by Institutions
‪53.10%‬
Price stats
Beta
‪1.55‬
50-Day Avg
‪6.14‬
200-Day Avg
‪4.53‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 8.10‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ATAI - AtaiBeckley Inc.
Peers - ATAI - AtaiBeckley Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ATAINASDAQAtaiBeckley Inc.2.73BMarket Cap+35.77%52-week change-2.54P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt62.93BMarket Cap+33.08%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.58BMarket Cap-87.93%52-week change40.23P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE28.34BMarket Cap+7.12%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.52BMarket Cap+21.81%52-week change19.30P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.84BMarket Cap+39.72%52-week change-21.44P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.59BMarket Cap+11.71%52-week change180.27P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ATAI - AtaiBeckley Inc.
About
AtaiBeckley Inc. is a clinical-stage biotechnology company focused on developing innovative treatments for mental health disorders. The company concentrates on psychedelic-based and other novel neuroactive compounds designed to offer rapid-acting, durable, and convenient therapeutic options for people with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
